A study to compare the disease severity between vaccinated and unvaccinated COVID 19 patients in Tumkur city

Sudheer K N, Savitha Rani B B, Greshma C Nair, Vinay K S, Gopinath S
{"title":"A study to compare the disease severity between vaccinated and unvaccinated COVID 19 patients in Tumkur city","authors":"Sudheer K N, Savitha Rani B B, Greshma C Nair, Vinay K S, Gopinath S","doi":"10.18231/j.ijfcm.2022.013","DOIUrl":null,"url":null,"abstract":"WHO declared coronavirus 2(SARS-CoV-2) as a pandemic on March 11, 2020. COVID-19 vaccines have been rapidly developed and distributed to help fight the pandemic. By January 2021, use of the Covishield vaccine and Covaxin vaccine use was approved. India began its vaccination program on 16 January 2021. The objective of the study is to assess the severity of COVID 19 infection among those vaccinated and unvaccinated as this will help us to assess the efficacy of the vaccines.By Convenient sampling technique the data of all those patients who were admitted in tertiary care centers in Tumkur district during second wave (April-July 2021) of COVID 19 infection were assessed from their medical records. The severity of the COVID 19 infection was assessed by evaluating the CT scores, lymphocyte/ neutrophil ratio, platelet distribution width, medical treatment provided and outcome which was later compared to vaccine status of the patients. Out of 220 patients in the study, 188(85.5%) were not vaccinated, 183(83.2%) had a positive RT PCR report, with most having CT of moderate changes (45.9%). Only 42(19.1%) patients underwent intubation and 28(12.7%) patients died. Using Chi Square test it was seen that those who were not vaccinated had moderate to severe CT scores (P = 0.026).Those who were not vaccinated had a higher chance of developing moderate to severe CT changes, though the death rate was less. Vaccine is found to be efficacious in fighting against COVID-19.","PeriodicalId":13276,"journal":{"name":"Indian journal of forensic and community medicine","volume":"10 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of forensic and community medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.ijfcm.2022.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

WHO declared coronavirus 2(SARS-CoV-2) as a pandemic on March 11, 2020. COVID-19 vaccines have been rapidly developed and distributed to help fight the pandemic. By January 2021, use of the Covishield vaccine and Covaxin vaccine use was approved. India began its vaccination program on 16 January 2021. The objective of the study is to assess the severity of COVID 19 infection among those vaccinated and unvaccinated as this will help us to assess the efficacy of the vaccines.By Convenient sampling technique the data of all those patients who were admitted in tertiary care centers in Tumkur district during second wave (April-July 2021) of COVID 19 infection were assessed from their medical records. The severity of the COVID 19 infection was assessed by evaluating the CT scores, lymphocyte/ neutrophil ratio, platelet distribution width, medical treatment provided and outcome which was later compared to vaccine status of the patients. Out of 220 patients in the study, 188(85.5%) were not vaccinated, 183(83.2%) had a positive RT PCR report, with most having CT of moderate changes (45.9%). Only 42(19.1%) patients underwent intubation and 28(12.7%) patients died. Using Chi Square test it was seen that those who were not vaccinated had moderate to severe CT scores (P = 0.026).Those who were not vaccinated had a higher chance of developing moderate to severe CT changes, though the death rate was less. Vaccine is found to be efficacious in fighting against COVID-19.
图尔库尔市接种疫苗和未接种疫苗的COVID - 19患者疾病严重程度的比较研究
世卫组织于2020年3月11日宣布冠状病毒2(SARS-CoV-2)为大流行。COVID-19疫苗已迅速开发和分发,以帮助抗击大流行。到2021年1月,批准使用Covishield疫苗和Covaxin疫苗。印度于2021年1月16日启动了其疫苗接种规划。这项研究的目的是评估接种疫苗和未接种疫苗的人感染COVID - 19的严重程度,这将有助于我们评估疫苗的有效性。采用便捷抽样技术,对第二波(2021年4月至7月)在图姆库尔地区三级医疗中心收治的所有患者的病历数据进行评估。通过CT评分、淋巴细胞/中性粒细胞比值、血小板分布宽度、所接受的治疗及转诊结果与患者疫苗接种情况进行比较,评估患者感染的严重程度。在该研究的220例患者中,188例(85.5%)未接种疫苗,183例(83.2%)RT - PCR报告阳性,大多数CT显示中度变化(45.9%)。42例(19.1%)患者接受了插管,28例(12.7%)患者死亡。卡方检验显示,未接种疫苗者CT评分为中度至重度(P = 0.026)。未接种疫苗的人发生中度至重度CT改变的几率更高,但死亡率较低。疫苗被发现对抗击COVID-19有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信